Report Detail

Summary

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Perfusion Bioreactors market in this environment.

In terms of revenue, this research report indicated that the global Perfusion Bioreactors market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Perfusion Bioreactors industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Merck aims at producing XX Perfusion Bioreactors in 2020, with XX % production to take place in global market, FiberCell Systems accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Perfusion Bioreactors Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Perfusion Bioreactors Market?
Merck
FiberCell Systems
Zellwerk GmbH
Cell Culture Company
ATMI Incorporated
PBS Biotech
GE Healthcare Life Sciences
Applikon Biotechnology
WAVE Life Sciences
...
Major Type of Perfusion Bioreactors Covered in XYZResearch report:
Small Scale Perfusion Bioreactors (50 liters to 1,000 liters)
Large Scale Perfusion Bioreactors (>1,000 liters)
Application Segments Covered in XYZResearch Market
Biopharmaceutical Companies
Biotechnology Companies
Contract Manufacturing Organizations (CMOs)

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

    Global Perfusion Bioreactors Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

      1 Market Scope

      • 1.1 Product Details and Introduction
        • 1.1.1 Small Scale Perfusion Bioreactors (50 liters to 1,000 liters) -Product Introduction and Major Manufacturers
        • 1.1.2 Large Scale Perfusion Bioreactors (>1,000 liters) -Product Introduction and Major Manufacturers
      • 1.2 Market Snapshot
        • 1.2.1 Major Companies Overview
        • 1.2.2 Market Concentration
        • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

      2 Global Perfusion Bioreactors Market Assessment, by Segmentation

      • 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
      • 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
      • 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)

      3 Regional Market Analysis

      • 3.1 China Perfusion Bioreactors Market
        • 3.1.1 Top Companies leading Perfusion Bioreactors Development in China (2015-2020)
        • 3.1.2 Sales Value of Major Company in China Market (2015-2020)
        • 3.1.3 China Perfusion Bioreactors Price (USD/Unit), by Type (2019-2020)
        • 3.1.4 Sales in China Market, by Type (2015-2026)
      • 3.2 EU Perfusion Bioreactors Market
        • 3.2.1 Top Companies leading Perfusion Bioreactors Development in EU (2015-2020)
        • 3.2.2 Sales Value of Major Company in EU Market (2015-2020)
        • 3.2.3 EU Perfusion Bioreactors Price (USD/Unit), by Type (2019-2020)
        • 3.2.4 Sales in EU Market, by Type (2015-2026)
      • 3.3 USA Perfusion Bioreactors Market
        • 3.3.1 Top Companies leading Perfusion Bioreactors Development in USA (2015-2020)
        • 3.3.2 Sales Value of Major Company in USA Market (2015-2020)
        • 3.3.3 USA Perfusion Bioreactors Price (USD/Unit), by Type (2019-2020)
        • 3.3.4 Sales in USA Market, by Type (2015-2026)
      • 3.4 Japan Perfusion Bioreactors Market
        • 3.4.1 Top Companies leading Perfusion Bioreactors Development in Japan (2015-2020)
        • 3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
        • 3.4.3 Japan Perfusion Bioreactors Price (USD/Unit), by Type (2019-2020)
        • 3.4.4 Sales in Japan Market, by Type (2015-2026)
      • 3.5 India Perfusion Bioreactors Market
        • 3.5.1 Top Companies leading Perfusion Bioreactors Development in India (2015-2020)
        • 3.5.2 Sales Value of Major Company in India Market (2015-2020)
        • 3.5.3 India Perfusion Bioreactors Price (USD/Unit), by Type (2019-2020)
        • 3.5.4 Sales in India Market, by Type (2015-2026)
      • 3.6 Southeast Asia Perfusion Bioreactors Market
        • 3.6.1 Top Companies leading Perfusion Bioreactors Development in Southeast Asia (2015-2020)
        • 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
        • 3.6.3 Southeast Asia Perfusion Bioreactors Price (USD/Unit), by Type (2019-2020)
        • 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
      • 3.7 South America Perfusion Bioreactors Market
        • 3.7.1 Top Companies leading Perfusion Bioreactors Development in South America (2015-2020)
        • 3.7.2 Sales Value of Major Company in South America Market (2015-2020)
        • 3.7.3 South America Perfusion Bioreactors Price (USD/Unit), by Type (2019-2020)
        • 3.7.4 Sales in South America Market, by Type (2015-2026)

      4 Value Chain (Impact of COVID-19)

      • 4.1 Perfusion Bioreactors Value Chain Analysis
        • 4.1.1 Upstream
        • 4.1.2 Downstream
      • 4.2 COVID-19 Impact on Perfusion Bioreactors Industry
        • 4.2.1 Industrial Policy Issued Under the Epidemic Situation
      • 4.3 Cost-Under the Epidemic Situation
        • 4.3.1 Cost of Raw Material
      • 4.4 Channel Analysis
        • 4.4.1 Distribution Channel-Under the Epidemic Situation
        • 4.4.2 Distributors

      5 Regional Market Forecast (2021-2026)

      • 5.1 Global Perfusion Bioreactors Sales and Growth Rate (2021-2026)
      • 5.2 Global Perfusion Bioreactors Sales Value and Growth Rate (2021-2026)

      6 Perfusion Bioreactors Competitive Analysis

      • 6.1 Merck
        • 6.1.1 Merck Company Profiles
        • 6.1.2 Merck Product Introduction
        • 6.1.3 Merck Perfusion Bioreactors Production, Revenue (2015-2020)
        • 6.1.4 SWOT Analysis
      • 6.2 FiberCell Systems
        • 6.2.1 FiberCell Systems Company Profiles
        • 6.2.2 FiberCell Systems Product Introduction
        • 6.2.3 FiberCell Systems Perfusion Bioreactors Production, Revenue (2015-2020)
        • 6.2.4 SWOT Analysis
      • 6.3 Zellwerk GmbH
        • 6.3.1 Zellwerk GmbH Company Profiles
        • 6.3.2 Zellwerk GmbH Product Introduction
        • 6.3.3 Zellwerk GmbH Perfusion Bioreactors Production, Revenue (2015-2020)
        • 6.3.4 SWOT Analysis
      • 6.4 Cell Culture Company
        • 6.4.1 Cell Culture Company Company Profiles
        • 6.4.2 Cell Culture Company Product Introduction
        • 6.4.3 Cell Culture Company Perfusion Bioreactors Production, Revenue (2015-2020)
        • 6.4.4 SWOT Analysis
      • 6.5 ATMI Incorporated
        • 6.5.1 ATMI Incorporated Company Profiles
        • 6.5.2 ATMI Incorporated Product Introduction
        • 6.5.3 ATMI Incorporated Perfusion Bioreactors Production, Revenue (2015-2020)
        • 6.5.4 SWOT Analysis
      • 6.6 PBS Biotech
        • 6.6.1 PBS Biotech Company Profiles
        • 6.6.2 PBS Biotech Product Introduction
        • 6.6.3 PBS Biotech Perfusion Bioreactors Production, Revenue (2015-2020)
        • 6.6.4 SWOT Analysis
      • 6.7 GE Healthcare Life Sciences
        • 6.7.1 GE Healthcare Life Sciences Company Profiles
        • 6.7.2 GE Healthcare Life Sciences Product Introduction
        • 6.7.3 GE Healthcare Life Sciences Perfusion Bioreactors Production, Revenue (2015-2020)
        • 6.7.4 SWOT Analysis
      • 6.8 Applikon Biotechnology
        • 6.8.1 Applikon Biotechnology Company Profiles
        • 6.8.2 Applikon Biotechnology Product Introduction
        • 6.8.3 Applikon Biotechnology Perfusion Bioreactors Production, Revenue (2015-2020)
        • 6.8.4 SWOT Analysis
      • 6.9 WAVE Life Sciences
        • 6.9.1 WAVE Life Sciences Company Profiles
        • 6.9.2 WAVE Life Sciences Product Introduction
        • 6.9.3 WAVE Life Sciences Perfusion Bioreactors Production, Revenue (2015-2020)
        • 6.9.4 SWOT Analysis

      7 Conclusion

      Summary:
      Get latest Market Research Reports on PERFUSION BIOREACTORS. Industry analysis & Market Report on PERFUSION BIOREACTORS is a syndicated market report, published as Post-pandemic Era-Global Perfusion Bioreactors Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026. It is complete Research Study and Industry Analysis of PERFUSION BIOREACTORS market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,650.00
      $5,600.00
      2,821.45
      4,328.80
      3,398.15
      5,213.60
      557,318.50
      855,064.00
      308,060.00
      472,640.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report